A new prediction model integrated serum lipid profile for patients with multiple myeloma

Wang, Huizhong; Chen, Biyun; Shao, Ruonan; Liu, Wenjian; Xiong, Lang; Li, Li; Lu, Yue

doi:10.7150/jca.69321



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(6):1796-1807. doi:10.7150/jca.69321 This issue Cite

Research Paper

A new prediction model integrated serum lipid profile for patients with multiple myeloma

Huizhong Wang^1,2,3*, Biyun Chen^1,2,3*, Ruonan Shao^1,2,3*, Wenjian Liu^1,2,3*, Lang Xiong^1,2,3, Li Li^1,2,3✉, Yue Lu^1,2,3✉

1. Sun Yat-sen University Cancer Center, Guangzhou, China.
2. State Key Laboratory of Oncology in South China, Guangzhou, China.
3. Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
*Equal contribution

Citation:

Wang H, Chen B, Shao R, Liu W, Xiong L, Li L, Lu Y. A new prediction model integrated serum lipid profile for patients with multiple myeloma. J Cancer 2022; 13(6):1796-1807. doi:10.7150/jca.69321. https://www.jcancer.org/v13p1796.htm

Other styles

Abstract

Purpose: This study aimed to explore a predictive risk-stratification model combing clinical characteristics and lipid profiles in multiple myeloma (MM) patients.

Methods: The data of 275 patients in Sun Yat-Sen University Cancer Center were retrospectively analyzed and randomly divided into the training (n = 138) and validation (n=137) cohorts. Triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), lactate dehydrogenase (LDH), Apolipoprotein B (Apo B) and Apo B/Apolipoprotein A1 (Apo A1) ratio were the prognostic factors identified through univariate and multivariate Cox analysis.

Results: A 6-prognostic factor model was constructed based on Lasso regression. Patients were divided into low- and high-risk groups and the former group showed longer overall survival (OS) time (p<0.05). The area under the curve (AUC) of the risk score model for 5-and 10-year OS were 0.756 [95% CI: 0.661-0.850] and 0.940 [95% CI: 0.883-0.997], which exhibited better accuracy than International Staging System (ISS) and Durie and Salmon (DS) stage.

Conclusion: This study aims to combine the lipid metabolism profile with the clinical characteristics of MM patients to generate a prognostic model. The nomogram integrating ISS stage and risk score increased the prediction accuracy. This model can monitor lipid profile as a simple and effective method, which has certain clinical significance for improving the accuracy of the prognosis and exploring potential therapeutic targets.

Keywords: multiple myeloma, lipid profile, metabolism, prognostic model

Citation styles

APA

Wang, H., Chen, B., Shao, R., Liu, W., Xiong, L., Li, L., Lu, Y. (2022). A new prediction model integrated serum lipid profile for patients with multiple myeloma. Journal of Cancer, 13(6), 1796-1807. https://doi.org/10.7150/jca.69321.

ACS

Wang, H.; Chen, B.; Shao, R.; Liu, W.; Xiong, L.; Li, L.; Lu, Y. A new prediction model integrated serum lipid profile for patients with multiple myeloma. J. Cancer 2022, 13 (6), 1796-1807. DOI: 10.7150/jca.69321.

NLM

CSE

Wang H, Chen B, Shao R, Liu W, Xiong L, Li L, Lu Y. 2022. A new prediction model integrated serum lipid profile for patients with multiple myeloma. J Cancer. 13(6):1796-1807.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.